Company intelligence / Profile preview
Leonhardt Ventures
Mission Viejo, California, United Statesleonhardtventures.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Leonhardt Ventures is a clinical-stage medtech/biotech venture creation firm built around a core platform of programmable bioelectric stimulation and biologic compositions for organ regeneration and inflammation control, with multiple organ- or indication-specific startups in early clinical or first-in-human development.[1][2][3]
- Therapeutic areas
- EndocrinologyCardiovascularNeurologyDermatologyRheumatologyRare DiseasesOncology
- Modalities
- DeviceStem cell therapyBiologicHydrogel-based drug delivery therapyGene therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Core Manufacturing LLC – cGMP medical device manufacturing partnership[1]Collaboration with experienced test assay suppliers and a qualified San Diego laboratory for KlothoYears blood testing[2]
Beyond the preview
Go deeper on Leonhardt Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leonhardt Ventures.